As robots expand beyond manufacturing, what should developers know about new applications? Here are six examples of robotics needs.
J&J acquires Auris Health for $3.4B
Johnson & Johnson (J&J) is upping its robotic surgery play as its subsidiary Ethicon today inked a $3.4 billion deal to acquire Auris Health and its FDA-cleared Monarch platform. Auris is surgical robotics pioneer Dr. Fred Moll’s newest robotic surgical play. New Brunswick, N.J.-based Johnson & Johnson said the deal will include an additional $2.35 billion in milestone-based…
Auris Health raises $220M for medical robotics platform
Auris Health closed a $220 million equity financing round to support its next-generation Monarch robotic interventional platform. The funding round brings the total raised for the Auris Health Monarch surgical platform up to $700 million over four rounds, Auris Health said. Redwood City, Calif.-based Auris Health said the round was led by Partner Fund Management…
Auris Health wins FDA approval for Monarch surgical robot
Auris Health, previously known as Auris Surgical Robotics and formed by Intuitive Surgical (NSDQ:ISRG) founder Dr. Frederic Moll, won FDA clearance for its Monarch robotic endoscopy platform. The Redwood City, Calif.-based company said it’s Monarch robotic platform’s initial aim will be on treating lung cancer, with the FDA clearance indicating the device for use in…